Guangzhou Hexin Instrument Co., Ltd. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Net Sales has grown by an annual rate of -13.09% and Operating profit at -327.00% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times

The company has declared negative results for the last 2 consecutive quarters

Risky -

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CNY 1,591 Million (Mid Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.57

Return on Equity

-11.22%

Price to Book

4.13

Revenue and Profits:

Net Sales:

21 Million

(Quarterly Results - Jun 2025)

Net Profit:

-11 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

10.64%

6 Months

43.66%

1 Year

76.83%

2 Years

249.46%

3 Years

262.6%

4 Years

92.99%

5 Years

0.0%

Guangzhou Hexin Instrument Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Guangzhou Hexin Stock Hits Day High with 6.52% Surge on Strong Performance

Guangzhou Hexin Instrument Co., Ltd. has seen substantial stock gains, with a notable increase of 425.82% over the past year, significantly outperforming the China Shanghai Composite. However, the company is grappling with operating losses and a decline in net sales, reflecting challenges in its financial landscape.

Guangzhou Hexin Instrument Hits Day High with 15.29% Surge

Guangzhou Hexin Instrument Co., Ltd. has seen notable stock activity, with significant gains over various time frames. Despite impressive year-to-date and one-year performance figures, the company faces challenges such as operating losses, declining net sales, and a high debt-to-equity ratio, raising concerns about its financial health.

Guangzhou Hexin Instrument Hits Day High with 13.14% Surge

Guangzhou Hexin Instrument Co., Ltd. has seen notable stock performance, with significant increases over various time frames, including a 120.26% year-to-date gain. However, the company faces challenges such as operating losses and a high debt-to-equity ratio, raising concerns about its long-term growth potential in the pharmaceuticals and biotechnology sector.

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-13.09%

EBIT Growth (5y)

-327.00%

EBIT to Interest (avg)

-34.56

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.62

Sales to Capital Employed (avg)

0.37

Tax Ratio

9.65%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

2.58%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

4.13

EV to EBIT

-27.70

EV to EBITDA

-44.81

EV to Capital Employed

2.99

EV to Sales

12.13

PEG Ratio

Dividend Yield

ROCE (Latest)

-10.80%

ROE (Latest)

-11.22%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -63.33% vs -44.16% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -27.91% vs 54.01% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "20.50",
          "val2": "55.90",
          "chgp": "-63.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.80",
          "val2": "-2.30",
          "chgp": "-195.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.80",
          "val2": "2.20",
          "chgp": "-18.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.00",
          "val2": "-8.60",
          "chgp": "-27.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-623.30%",
          "val2": "-171.30%",
          "chgp": "-45.20%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -45.13% vs 30.79% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 51.02% vs -40.74% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "199.50",
          "val2": "363.60",
          "chgp": "-45.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-41.90",
          "val2": "-102.90",
          "chgp": "59.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.10",
          "val2": "10.40",
          "chgp": "-22.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-50.60",
          "val2": "-103.30",
          "chgp": "51.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-348.60%",
          "val2": "-362.70%",
          "chgp": "1.41%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

20.50

55.90

-63.33%

Operating Profit (PBDIT) excl Other Income

-6.80

-2.30

-195.65%

Interest

1.80

2.20

-18.18%

Exceptional Items

0.00

Consolidate Net Profit

-11.00

-8.60

-27.91%

Operating Profit Margin (Excl OI)

-623.30%

-171.30%

-45.20%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is -63.33% vs -44.16% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -27.91% vs 54.01% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

199.50

363.60

-45.13%

Operating Profit (PBDIT) excl Other Income

-41.90

-102.90

59.28%

Interest

8.10

10.40

-22.12%

Exceptional Items

-0.60

0.00

Consolidate Net Profit

-50.60

-103.30

51.02%

Operating Profit Margin (Excl OI)

-348.60%

-362.70%

1.41%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -45.13% vs 30.79% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 51.02% vs -40.74% in Dec 2023

All Annual Results

Company CV

About Guangzhou Hexin Instrument Co., Ltd.

Guangzhou Hexin Instrument Co., Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Guangzhou Hexin Instrument Co., Ltd.

1Day

52 Week

CASH

FII

DII

Promoter

MarketsMojo — Loved in India, Now Global

Dashboard

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

The company has declared negative results for the last 2 consecutive quarters

Risky -

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Guangzhou Hexin Stock Hits Day High with 6.52% Surge on Strong Performance

Guangzhou Hexin Instrument Hits Day High with 15.29% Surge

Guangzhou Hexin Instrument Hits Day High with 13.14% Surge

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About Guangzhou Hexin Instrument Co., Ltd.

Company Coordinates